Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ninian N Lang

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
European Heart Journal|May 21, 2023
Dapagliflozin vs. metolazone in heart failure resistant to loop diureticsSu Ern Yeoh, Joanna Osmanska, Mark C Petrie, et al.
Cardiovascular Research|May 26, 2026
Targeting RUNX1 protects against diastolic dysfunction in a two-hit mouse model of heart failure with preserved ejection fractionAli Ali Mohamed Elbassioni, Anmar A Raheem, Jian Song, et al.
Circulation. Cardiovascular Imaging|July 13, 2012
In vivo mononuclear cell tracking using superparamagnetic particles of iron oxide: feasibility and safety in humansJennifer M J Richards, Catherine A Shaw, Ninian N Lang, et al.
JACC. Cardiooncology|February 19, 2025
Cardiovascular Safety in Oncology Clinical Trials: JACC: CardioOncology PrimerMarc P Bonaca, Ninian N Lang, Alice Chen, et al.
European Heart Journal|May 2, 2026
Cancer and heart failure: prevalence, incidence, and prognosis in ScotlandAntonio Iaconelli, Moustafa I Morsy, Jocelyn M Friday, et al.
Circulation|November 13, 2020
Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)Matthew M Y Lee, Katriona J M Brooksbank, Kirsty Wetherall, et al.
Communications Medicine|February 28, 2024
Socioeconomic deprivation and illness trajectory in the Scottish population after COVID-19 hospitalizationAndrew J Morrow, Robert Sykes, Merna Saleh, et al.
Nature Medicine|May 23, 2022
A multisystem, cardio-renal investigation of post-COVID-19 illnessAndrew J Morrow, Robert Sykes, Alasdair McIntosh, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
European Heart Journal|May 21, 2023
Dapagliflozin vs. metolazone in heart failure resistant to loop diureticsSu Ern Yeoh, Joanna Osmanska, Mark C Petrie, et al.
Cardiovascular Research|May 26, 2026
Targeting RUNX1 protects against diastolic dysfunction in a two-hit mouse model of heart failure with preserved ejection fractionAli Ali Mohamed Elbassioni, Anmar A Raheem, Jian Song, et al.
Circulation. Cardiovascular Imaging|July 13, 2012
In vivo mononuclear cell tracking using superparamagnetic particles of iron oxide: feasibility and safety in humansJennifer M J Richards, Catherine A Shaw, Ninian N Lang, et al.
JACC. Cardiooncology|February 19, 2025
Cardiovascular Safety in Oncology Clinical Trials: JACC: CardioOncology PrimerMarc P Bonaca, Ninian N Lang, Alice Chen, et al.
European Heart Journal|May 2, 2026
Cancer and heart failure: prevalence, incidence, and prognosis in ScotlandAntonio Iaconelli, Moustafa I Morsy, Jocelyn M Friday, et al.
Circulation|November 13, 2020
Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)Matthew M Y Lee, Katriona J M Brooksbank, Kirsty Wetherall, et al.
Communications Medicine|February 28, 2024
Socioeconomic deprivation and illness trajectory in the Scottish population after COVID-19 hospitalizationAndrew J Morrow, Robert Sykes, Merna Saleh, et al.
Nature Medicine|May 23, 2022
A multisystem, cardio-renal investigation of post-COVID-19 illnessAndrew J Morrow, Robert Sykes, Alasdair McIntosh, et al.
Pageof 9